Use of the microculture kinetic assay of apoptosis to determine chemosensitivities of leukemias

Blood

Volumn 92, Issue 3, 1998, Pages 968-980

  Kravtsov, Vladimir D ^a   Greer, John P ^b   Whitlock, James A ^b   Koury, Mark J ^b  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; DAUNORUBICIN; IDARUBICIN; MITOXANTRONE;

ACUTE LYMPHOCYTIC LEUKEMIA; ACUTE NONLYMPHOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL STRAIN HL 60; CELL STRUCTURE; CHEMOSENSITIVITY; CHILD; CLINICAL ARTICLE; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LEUKEMIA; MALE; OPTICAL DENSITY; PRIORITY JOURNAL;

EID: 0032147020     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v92.3.968.415k27_968_980     Document Type: Article

References (50)

1. Preisler HD: Prediction of response to chemotherapy in acute myelocytic leukemia. Blood 56:361, 1980
2. Park CH, Amare M, Savin MA, Goodwin JW, Newcomb MM, Hoogstraten P: Prediction of chemotherapy response in human leukemia using an in vitro chemotherapy sensitivity test on the leukemic colony-forming cells. Blood 55:595, 1980
3. Park CH, Wiernik PH, Morrison FS, Amare M, vanSloten K, Maloney TR: Clinical correlations of leukemic clonogenic cell chemosensitivity assessed by in vitro continuous exposure to drugs. Cancer Res 43:2346, 1983
4. Pieters R, Huismans DR, Leyva A, Veerman AJP: Comparison of a rapid automated tetrazolium based (MTT)-assay with a dye exclusion assay for chemosensitivity testing in childhood leukaemia, Br J Cancer 59:217, 1989
5. Sargent JM, Taylor CG: Appraisal of the MTT assay as a rapid test of chemosensitivity in acute myeloid leukaemia. Br J Cancer 60:206, 1989
6. Twentyman PR, Fox NE, Rees JKH: Chemosensitivity testing of fresh leukaemia cells using the MTT colorimetric assay. Br J Haematol 71:19, 1989
7. Weisenthal LM, Dill PL, Finklestein JZ, Duarte TE, Baker JA, Moran EM: Laboratory detection of primary and acquired drug resistance in human lymphatic neoplasms. Cancer Treat Rep 70:1283, 1986
8. Veerman AJP, Pieters R: Drug sensitivity assays in leukaemia and lymphoma. Br J Haematol 74:381, 1990
9. Weisenthal L, Lippman M: Clonogenic and nonclonogenic in vitro chemosensitivity assays. Cancer Treat Rep 69:615, 1985
10. Fruehauf JP, Bosanquet AG: In vitro determination of drug response: A discussion of clinical applications. Principles Practice Oncol 7:1, 1993
11. Gorczyca W, Bigman K, Mittelman A, Ahmed T, Gong J, Melamed MR, Darzynkiewicz Z: Induction of DNA strand breaks associated with apoptosis during treatment of leukemias. Leukemia 7:659, 1993
12. Sachs L, Lotem J: Control of programed cell death in normal and leukemic cells: New implications for therapy. Blood 82:15, 1993
13. Kerr JFR, Winterford CM, Harmon BV: Apoptosis: Its significance in cancer and cancer therapy. Cancer 73:2013, 1994
14. Hannun YA: Apoptosis and the dilemma of cancer chemotherapy. Blood 89:1845, 1997
15. Wyllie AH: Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 284:555, 1980
16. Darzyukievicz Z, Bruno S, Del Bino G, Gorczyca W, Hotz MA, Lassota P, Traganos F: Features of apoptotic cells measured by flow cytometry. Cytometry 13:795, 1992
17. Wyllie AH, Kerr JFR, Currie AR: Cell death: The significance of apoptosis. Int Rev Cytol 68:251, 1980
18. Cejna M, Fritsch G, Printz D, Schulte-Herman R, Bursch W: Kinetics of apoptosis and secondary necrosis in cultured rat thymocytes and S.49 mouse lymphocytes and human leukemia cells. Biochem Cell Biol 72:677, 1994
19. Kravtsov V, Fabian I: Automated monitoring of apoptosis in suspension cell cultures. Lab Invest 74:557, 1996
20. Koopman G, Reutelingsperger CPM, Kuijten GAM, Keehen RMJ, Pals ST, van Oers MHJ: Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood 84:1415, 1994
21. Dosik GM, Barlogie B, Johnston D, Mellard D, Freierreich EJ: Dose-dependent suppression of DNA synthesis in vitro as a predictor of clinical response in adult acute myeloblastic leukemia. Eur J Cancer 17:549, 1981
22. Zwelling LA, Bales E, Altschuler E, Mayes J: Circumvention of resistance by doxorubicin, but not by idarubicin, in a human leukemia cell line containing an intercalator-resistant form of topoisomerase II. Biochem Pharmacol 45:516, 1993
23. Karp JE, Jones RJ, Miller CB, Schneider E, Zwelling LA, Cowan K, Wendel K, Burke PJ: Topoisomerase II levels and drug sensitivity in adult acute myelogenous leukemia. Blood 83:517, 1994
24. Bhalla K, Ibrado AM, Tourkina E, Tang C, Grant S, Bullock G, Huang Y, Ponnathpur V, Mahoney ME: High-dose mitoxantrone induces programmed cell death or apoptosis in human myeloid leukemia cells. Blood 82:3133, 1993
25. Alberts DS, Peng YM, Leigh S, Davis TP, Woodward DL: Disposition of mitoxantrone in cancer patients. Cancer Res 45:1879, 1985
26. Smyth JF, Macpherson JS, Warrington PS, Leonard RCF, Wolf CR: The clinical pharmacology of mitoxantrone. Cancer Chemother Parmacol 17:149, 1986
27. Banker DE, Groudine M, Norwood T, Appelbaum FR: Measurement of spontaneous and therapeutic agent-induced apoptosis with BCL-2 protein expression in acute myeloid leukemia. Blood 89:243, 1997
28. Waddick KG. Myers DE, Gunther R, Chelstrom LM, Chandan-Langlie M, Irvin JD. Turner N: In vitro and in vivo antileukemic activity of B43-pokeweed antiviral protein against radiation resistant human B-cell precursor leukemia cells. Blood 86:4228, 1995
29. Seiter K, Feldman EJ, Halicka HD. Traganos F, Darzynkiewicz Z, Lake D, Ahmed T: Phase I clinical and laboratory evaluation of topotecan and cytarabine in patients with acute leukemia. J Clin Oncol 15:44, 1997
30. Kerr JFR, Wyllie AH, Currie AR: Apoptosis: A basic biological phenomenon with wide ranging implications in tissue kinetics. Br J Cancer 26:239, 1972
31. Mullinger AM, Johnson RT: Perturbation of mammalian cell division III. The topography and kinetics of extrusion subdivision. J Cell Sci 22:243, 1976
32. Cohen JJ: Overview: Mechanisms of apoptosis. Immunol Today 14:126, 1993
33. Kravtsov VD: A novel microculture kinetic assay (MiCK assay) for malignant cell growth and chemosensitivity. Eur J Cancer 30A: 1564, 1994
34. Mower DA, Jr., Peckham DW, Illera VA, Fishbaugh JK, Stunz LL, Ashman RF: Decreased membrane phospholipid packing and decreased cell size precede DNA cleavage in mature mouse B cell apoptosis. J Immunol 152:4832, 1994
35. Martin SJ, Reutelingsperger CPM, McGahon AJ, Rader Ja, van Schie RCAA, LaFace DM, Green DR: Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: Inhibition by overexpression of Bcl-2 and Abl. J Exp Med 182:1545, 1995
36. Castedo M, Hirsch T, Susin SA, Zamzami N, Marchetti P, Macho A, Kroemer G: Sequential acquisition of mitochondrial and plasma membrane alterations during early lymphocyte apoptosis. J Immunol 157:512, 1996
37. Savill JS, Fadok V, Henson P, Haslett C: Phagocyte recognition of cells undergoing apoptosis. Immunol Today 14:131, 1993
38. Cohen GM, Sun X-M, Snowden RT. DinsdaleD, Skilleter DN: Key morphological features of apoptosis may occur in the absence in internucleosomal DNA fragmentation. Biochem J 286:331, 1992
39. Collins RJ, Harmon BV, Gobe GC, Kerr JFR: Internucleosomal DNA cleavage should not be the sole criterion for identifying apoptosis. Int J Radiat Biol 61:451, 1992
40. Oberhammer F, Bursch W, Parzefall W, Breit P, Erber E, Stadler M, Schuhe-Hermann R: Effect of transforming growth factor β on cell death of cultured rat hepatocytes. Cancer Res 51:2478, 1991
41. Tomei LD, Shapiro JP, Cope FO: Apoptosis in C3H/10T1/2 mouse embryonic cells: Evidence for internucleosomal DNA modification in the absence of double-strand cleavage. Proc Natl Acad Sci USA 90:853, 1993
42. Jacobson MD, Burne JF, Raff MC: Programmed cell death and Bcl-2 protection in the absence of a nucleus. EMBO J 13:1899, 1994
43. Schulze-Osthoff K, Walczak H, Droge W, Krammer PH: Cell nucleus and DNA fragmentation are not required for apoptosis. J Cell Biol 127:15, 1994
44. Ray SD, Sorge CL, Kamendulis LM, Corcoran GB: Ca++-activated DNA fragmentation and dimethylnitrosamine-induced hepatic necrosis: Effects of Ca++-endonuclease and poly(ADP-ribose) polymerase inhibitors in mice. J Pharmacol Exp Ther 263:387, 1992
45. Fukuda K, Kojiro M, Chiu J-F: Demonstration of extensive chromatin cleavage in transplanted morris hepatoma 7777 tissue: Apoptosis or necrosis? Am J Pathol 142:935, 1993
46. Columbano A: Cell death: Current difficulties in discriminating apoptosis from necrosis in the context of pathological processes in vivo. J Cell Biochem 58:181, 1995
47. Ingram CF, Davidoff AN, Marais E, Sherman GG, Mendelow BV: Evaluation of DNA analysis for evidence of apoptosis in megaloblastic anemia. Br J Haematol 96:576, 1997
48. Vermes I, Haanen C, Richel DJ, Schaafsma MR, Kalsbeek-Batenburg E, Reutelingsperger CPM: Apoptosis and secondary necrosis of lymphocytes in cultures. Acta Hematol 98:8, 1997
49. Bergamo A, Bataille R, Pellat-Deceunynck C: CD40 and CD95 induce programmed cell death in the human myeloma cell line XG2. Br J Haematol 97:652, 1997
50. Ormerod MG, Orr RM, Peacock JH: The role of apoptosis in cell killing by cisplatin: A flow cytometry study. Br J Cancer 69:104, 1993